Authors:
Kucera, GL
Goff, CL
Iyer, N
Morris-Natschke, S
Ishaq, KS
Wyrick, SD
Fleming, RA
Kucera, LS
Citation: Gl. Kucera et al., Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity, ANTIVIR RES, 50(2), 2001, pp. 129-137
Citation: Ny. Choksi et al., A novel phenylaminotetralin (PAT) recognizes histamine H-1 receptors and stimulates dopamine synthesis in vivo in rat brain, BRAIN RES, 852(1), 2000, pp. 151-160
Citation: Fr. Luo et al., High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin, J CHROMAT B, 724(2), 1999, pp. 345-356
Citation: Fr. Luo et al., Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats, CANC CHEMOT, 44(1), 1999, pp. 19-28
Citation: Fr. Luo et al., Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model, CANC CHEMOT, 44(1), 1999, pp. 29-38
Citation: Ec. Bucholtz et al., Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H-1 receptors, J MED CHEM, 42(16), 1999, pp. 3041-3054
Citation: Rg. Booth et al., Putative sigma(3) sites in mammalian brain have histamine H-1 receptor properties: evidence from ligand binding and distribution studies with the novel H-1 radioligand [(3) H]-(-)-trans-1-phenyl-3-aminotetralin, BRAIN RES, 837(1-2), 1999, pp. 95-105
Authors:
Holmes, J
Stanko, J
Varchenko, M
Ding, H
Madden, VJ
Bagnell, CR
Wyrick, SD
Chaney, SG
Citation: J. Holmes et al., Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model, TOXICOL SCI, 46(2), 1998, pp. 342-351
Citation: Fr. Luo et al., Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells, ONCOL RES, 10(11-12), 1998, pp. 595-603